Nippon India Nifty Pharma Etf - Growth

  • 3 Months
  • 6 Months
  • 1 Year
  • 3 Years
  • 5 Years
  • RSI
3 Months Returns : -1.50%
NAV: ₹22.93 as on Mon Nov 10, 2025
Fund NAV

Fund Overview of Nippon India Nifty Pharma Etf - Growth

  • ₹942.0 Cr
    AUM
  • ₹22.93
    NAV
  • 0.21%
    Expense Ratio
  • Equity
    Fund Category
As on Mon Nov 10, 2025

Returns of Nippon India Nifty Pharma Etf - Growth

Tenure Absolute(%) Annualised(%) Category Average(%)
3 Months -1.50% NA 6.12%
6 Months 8.09% NA 12.92%
1 Year -6.46% -6.46% 6.04%
2 Years 45.76% 20.73% 24.93%
3 Years 72.65% 19.96% 25.71%
View More
As on Mon Nov 10, 2025

Asset Allocation

equities

99.97%

debt instruments

0.00%

other assets or cash equivalents

0.03%
Large Cap: 70.51%
Mid Cap: 23.91%
Small Cap: 5.58%
Other: 0.00%
Top Holdings
Sun Pharmaceutical Industries Ltd
21.62%
Sun Pharmaceutical Industries Ltd
21.62%
Sun Pharmaceutical Industries Ltd
22.48%
Cipla Ltd
10.88%
Cipla Ltd
10.88%
 
Top Sectors
Healthcare
299.68%
Unspecified
0.32%
Detailed Portfolio Analysis
As on Mon Nov 10, 2025
Invest Now

About Fund

About Nippon India Nifty Pharma Etf - Growth

Nippon India Nifty Pharma Etf - Growth is one Equity mutual fund offered by Nippon India Mutual Fund. Launched on 02 Jul 2021, the fund aims Long term capital growth. Investment in equity and equity related securities and portfolios replicating the composition of Nifty Pharma Index, subject to tracking errors. It manages assets worth ₹942.0 crore as on Thu Jul 31, 2025. The expense ratio stands at 0.21%.
The portfolio allocation consists of 99.97% in equities, 0.00% in debt instruments, 0.03% in other assets or cash equivalents. Managed by Jitendra Tolani, it has delivered a return of -6.46% in the last year, a total return since inception of 10.81%.

Read more
  • Jitendra Tolani

    Fund Manager

  • MBA (FINANCE)

    Manager Education

Key Metrics of Nippon India Nifty Pharma Etf - Growth

  • Standard Deviation
    16.73%
  • Sharpe Ratio
    0.82%
  • Alpha
    -3.48%
  • Beta
    1.01%

Fund Details

Fund Names Nippon India Nifty Pharma Etf - Growth
Inception Date 02 Jul 2021
Lock In No Lock-in
 
Risk Principal at very high risk
Category Average Annual Returns 6.04
More Details
Highest NAV in last 52 weeks & Lowest NAV in last 52 weeks

Top Performing Mutual Funds

Fund Names AUM (Cr) 1M 3M 1Yr 3Yr 5Yr
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth trend ₹6,104 -0.69% 3.29% 4.56% 28.17% 22.19%
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth trend ₹6,104 -0.77% 3.06% 3.67% 27.07% 21.12%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth trend ₹872 -0.12% 2.45% 1.23% 23.22% 18.47%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth trend ₹872 -0.22% 2.10% -0.06% 21.58% 16.80%
increase growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns

More funds from Nippon India Mutual Fund

Fund Names AUM (Cr) 1M 3M 6M 1Yr 3Yr
Nippon India Pharma Fund-growth increase ₹8,737 -0.03% 2.09% 5.85% -0.43% 21.36%
Nippon India Pharma Fund Direct-growth increase ₹8,737 0.05% 2.33% 6.34% 0.48% 22.45%
Nippon India Pharma Fund-idcw increase ₹8,737 -0.03% 2.09% 5.85% -0.43% 21.36%
Nippon India Pharma Fund Direct-idcw increase ₹8,737 0.05% 2.33% 6.34% 0.48% 22.45%
increase growth is based on 1-month returns of the funds

Mutual Fund Calculator

I want to invest Pro Tip
Financial experts suggest that a person should invest 10-15% of their monthly income for long-term financial growth
/Month
I want to invest for Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 29
  • 31
  • 32
  • 33
  • 34
  • 36
  • 37
  • 38
  • 39
  • 40
Expected return Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 30
Total Investment
Wealth Gained
Total Wealth
Start Investing
I want to save
I want to invest for Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 29
  • 31
  • 32
  • 33
  • 34
  • 36
  • 37
  • 38
  • 39
  • 40
Expected return Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 30
Total Investment
Wealth Gained
Monthly Investment
Invest Now
You can also get Tax Free Maturity/ Returns? You can also get Tax Free Maturity/ Returns?

Top Mutual Funds

Fund Names AUM (Cr) NAV 3Yr 5Yr 10Yr
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth trend ₹6,104 ₹43.36 28.17% 22.19% -
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth trend ₹6,104 ₹40.14 27.07% 21.12% -
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth trend ₹872 ₹31.16 21.58% 16.80% -
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth trend ₹872 ₹34.35 23.22% 18.47% -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.05 22.09% - -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.05 22.09% - -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.05 22.09% - -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.05 22.09% - -
View More
Top funds are based on Fund AUM

Detailed Portfolio

Stocks Sector % of Holding Value
Sun Pharmaceutical Industries LtdHealthcare21.62%₹214.13 Cr
Sun Pharmaceutical Industries LtdHealthcare21.62%₹214.13 Cr
Sun Pharmaceutical Industries LtdHealthcare22.48%₹211.78 Cr
Cipla LtdHealthcare10.88%₹107.76 Cr
Cipla LtdHealthcare10.88%₹107.76 Cr
Cipla LtdHealthcare10.68%₹100.63 Cr
Divi's Laboratories LtdHealthcare10.23%₹96.37 Cr
Dr. Reddy's Laboratories LtdHealthcare9.59%₹95.01 Cr
Dr. Reddy's Laboratories LtdHealthcare9.59%₹95.01 Cr
Divi's Laboratories LtdHealthcare9.30%₹92.11 Cr
Divi's Laboratories LtdHealthcare9.30%₹92.11 Cr
Dr. Reddy's Laboratories LtdHealthcare9.45%₹89.01 Cr
Lupin LtdHealthcare5.95%₹58.93 Cr
Lupin LtdHealthcare5.95%₹58.93 Cr
Lupin LtdHealthcare5.70%₹53.68 Cr
Torrent Pharmaceuticals LtdHealthcare4.85%₹48.03 Cr
Torrent Pharmaceuticals LtdHealthcare4.85%₹48.03 Cr
Torrent Pharmaceuticals LtdHealthcare4.78%₹45.04 Cr
Laurus Labs LtdHealthcare4.21%₹41.68 Cr
Laurus Labs LtdHealthcare4.21%₹41.68 Cr
Laurus Labs LtdHealthcare4.18%₹39.38 Cr
Alkem Laboratories LtdHealthcare3.93%₹38.93 Cr
Alkem Laboratories LtdHealthcare3.93%₹38.93 Cr
Aurobindo Pharma LtdHealthcare3.90%₹38.63 Cr
Aurobindo Pharma LtdHealthcare3.90%₹38.63 Cr
Glenmark Pharmaceuticals LtdHealthcare3.78%₹37.48 Cr
Glenmark Pharmaceuticals LtdHealthcare3.78%₹37.48 Cr
Glenmark Pharmaceuticals LtdHealthcare3.93%₹36.98 Cr
Aurobindo Pharma LtdHealthcare3.89%₹36.68 Cr
Mankind Pharma Ltd.Healthcare3.54%₹35.10 Cr
Mankind Pharma Ltd.Healthcare3.54%₹35.10 Cr
Mankind Pharma Ltd.Healthcare3.54%₹33.37 Cr
Zydus Lifesciences LtdHealthcare3.16%₹31.26 Cr
Zydus Lifesciences LtdHealthcare3.16%₹31.26 Cr
Alkem Laboratories LtdHealthcare3.31%₹31.16 Cr
Zydus Lifesciences LtdHealthcare2.96%₹27.87 Cr
Biocon LtdHealthcare2.87%₹27.05 Cr
Biocon LtdHealthcare2.64%₹26.10 Cr
Biocon LtdHealthcare2.64%₹26.10 Cr
Ipca Laboratories LtdHealthcare2.39%₹23.72 Cr
Ipca Laboratories LtdHealthcare2.39%₹23.72 Cr
Ipca Laboratories LtdHealthcare2.50%₹23.57 Cr
Abbott India LtdHealthcare2.19%₹20.67 Cr
Gland Pharma LtdHealthcare2.04%₹20.20 Cr
Gland Pharma LtdHealthcare2.04%₹20.20 Cr
Abbott India LtdHealthcare1.97%₹19.47 Cr
Abbott India LtdHealthcare1.97%₹19.47 Cr
Gland Pharma LtdHealthcare2.01%₹18.91 Cr
Jb Chemicals & Pharmaceuticals LtdHealthcare1.79%₹17.74 Cr
Jb Chemicals & Pharmaceuticals LtdHealthcare1.79%₹17.74 Cr
Jb Chemicals & Pharmaceuticals LtdHealthcare1.75%₹16.50 Cr
Wockhardt LtdHealthcare1.61%₹15.96 Cr
Wockhardt LtdHealthcare1.61%₹15.96 Cr
Piramal Pharma LtdHealthcare1.52%₹15.06 Cr
Piramal Pharma LtdHealthcare1.52%₹15.06 Cr
Ajanta Pharma LtdHealthcare1.41%₹13.33 Cr
Ajanta Pharma LtdHealthcare1.30%₹12.91 Cr
Ajanta Pharma LtdHealthcare1.30%₹12.91 Cr
Natco Pharma LtdHealthcare1.04%₹9.83 Cr
Granules India LtdHealthcare0.84%₹7.93 Cr
Net Current AssetsUnspecified0.23%₹2.04 Cr
RepoUnspecified0.20%₹1.96 Cr
RepoUnspecified0.20%₹1.96 Cr
RepoUnspecified0.03%₹0.24 Cr
Others Mrgn MoneyUnspecified0.00%₹0.01 Cr
Others Mrgn MoneyUnspecified0.00%₹0.01 Cr
Others Mrgn MoneyUnspecified0.00%₹0.00 Cr
Net PayablesUnspecified-0.17%₹-1.62 Cr
Net PayablesUnspecified-0.17%₹-1.62 Cr
View More

Top Equity Funds

Fund Names NAV 3Yr 5Yr 52 weeks high
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth increase ₹43.36 28.17% 22.19% 44.69
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth increase ₹40.14 27.07% 21.12% 41.47
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth increase ₹34.35 23.22% 18.47% -
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth increase ₹31.16 21.58% 16.80% -
increase growth is based on 5Y returns of the funds

Frequently Asked Questions

Nippon India Nifty Pharma Etf - Growth

What is the current AUM of Nippon India Nifty Pharma Etf - Growth?

As of Thu Jul 31, 2025, Nippon India Nifty Pharma Etf - Growth manages assets worth ₹942.0 crore

How has Nippon India Nifty Pharma Etf - Growth performed recently?

  • 3 Months: -1.50%
  • 6 Months: 8.09%

What is the long-term performance of Nippon India Nifty Pharma Etf - Growth?

  • 3 Years CAGR: 19.96%
  • Since Inception: 10.81%

What is the portfolio composition of Nippon India Nifty Pharma Etf - Growth?

Equity: 99.97%, Debt: 0.00%, Others: 0.03%.

Who manages Nippon India Nifty Pharma Etf - Growth?

Nippon India Nifty Pharma Etf - Growth is managed by Jitendra Tolani from Nippon India Mutual Fund.

What is the market-cap allocation of Nippon India Nifty Pharma Etf - Growth?

Large Cap: 70.51%, Mid Cap: 23.91%, Small Cap: 5.58%.

Which are the top companies Nippon India Nifty Pharma Etf - Growth has invested in?

  • Sun Pharmaceutical Industries Ltd – 21.62% of the fund's portfolio
  • Sun Pharmaceutical Industries Ltd – 21.62% of the fund's portfolio
  • Sun Pharmaceutical Industries Ltd – 22.48% of the fund's portfolio
  • Cipla Ltd – 10.88% of the fund's portfolio
  • Cipla Ltd – 10.88% of the fund's portfolio

Which are the major sectors Nippon India Nifty Pharma Etf - Growth focuses on?

  • Healthcare – 299.68% of the fund's portfolio
  • Unspecified – 0.32% of the fund's portfolio
View more FAQ's

Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.

Please consult your financial advisor for an informed decision.

Past performance may not be indicative of future results.

The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.

Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.

Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.

For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.

For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.

Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved

^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.

Explore the popular searches and stay informed

Close
Download the Policybazaar app
to manage all your insurance needs.
INSTALL
Claude
top

Become a Crorepati

Invest ₹10K/Month & Get ₹1 Crore# Returns

Mobile +91
*T&C Applied.